Adding camrelizumab and rivoceranib to transarterial chemoembolization (TACE) significantly prolonged progression-free ...

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...

Marissa Antonio was just 39 when the 19cm tumour was discovered - and now, Cancer Research UK has revealed liver cancer death ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...

A 39 year old nurse has recalled the four key symptoms that potentially saved her life, as she opened up about her critical ...

A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing serious liver ...

Long classified as a subset of common liver cancer, FLC should be considered its own unique disease. Now researchers are testing a combination drug therapy that targets FLC tumors.

Deaths from liver cancer are projected to increase by a further 10 per cent by 2040, but a charity says half of all cases ...

Brits are being urged to look out for some of the telltale signs of a deadly disease as shocking new figures show death rates ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...